基化疗减弱了CD8 T细胞对同时发生的PD-1阻塞的效应器反应
Annapaola Mariniello1,2,3,4, Tahseen H Nasti1,2, Daniel Y Chang1,2
1Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
概括
化学疗法与PD-1阻断相结合会损害肺癌中CD8T细胞的反应. 顺序管理,而不是并发,保持T细胞功能,以获得更好的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 组合化疗和编程细胞死亡1 (PD-1) 阻断是标准的肺癌治疗方法.
- 化疗对T细胞耗尽和对PD-1阻断的反应的影响尚未完全理解.
研究的目的:
- 研究化疗如何影响 CD8 T 细胞对 PD-1 阻断的反应.
- 为了比较化学疗法和PD-1阻断的同时与顺序给予的疗效.
主要方法:
- 使用了一种由慢性淋巴细胞胆膜炎病毒 (LCMV) 感染引起的T细胞疲劳的小鼠模型.
- 单独或与PD-1阻断联合使用的化疗 (cisplatin+pemetrexed).
- 评估T细胞分化,扩张,细胞因子生产 (IFNγ) 和病毒控制.
主要成果:
- 同时使用PD-1阻断的化疗阻碍了CD8T细胞分化和IFNγ产生,导致病毒控制受损.
- 连续施用 (PD-1 阻断,随后进行化疗) 效果优越,保留T细胞增殖反应.
- 静止的干状CD8T细胞受到化疗的影响较小,但在PD-1阻塞期间,它们的扩张受到抑制.
结论:
- 化疗的时间对CD8T细胞功能与PD-1阻断结合而言具有关键影响.
- 序列化疗-免疫疗法策略可以通过保护T细胞效应器功能来增强抗瘤免疫力.
- 这些发现为在临床环境中优化化疗免疫治疗时间提供了概念验证.
相关概念视频
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K